Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa

Peter U Fischer; Christopher L King; Julie A Jacobson; Gary J Weil

doi:10.1371/journal.pntd.0005163

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa

PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005163. doi: 10.1371/journal.pntd.0005163. eCollection 2017 Jan.

Authors

Peter U Fischer¹, Christopher L King², Julie A Jacobson³, Gary J Weil¹

Affiliations

¹ Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
² Case Western Reserve University, Cleveland, Ohio, United States of America.
³ Bill and Melinda Gates Foundation, Seattle, Washington, United States of America.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Africa / epidemiology
Albendazole / administration & dosage
Albendazole / therapeutic use*
Anthelmintics / administration & dosage
Anthelmintics / therapeutic use*
Diethylcarbamazine / administration & dosage
Diethylcarbamazine / therapeutic use*
Drug Therapy, Combination
Elephantiasis, Filarial / drug therapy*
Elephantiasis, Filarial / epidemiology
Elephantiasis, Filarial / prevention & control
Humans
Ivermectin / administration & dosage
Ivermectin / therapeutic use*
Onchocerciasis / drug therapy*
Onchocerciasis / epidemiology
Onchocerciasis / prevention & control

Substances

Anthelmintics
Ivermectin
Albendazole
Diethylcarbamazine

Grants and funding

This work was supported by a grant of the Bill & Melinda Gates Foundation (GH5342). The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The funders advised on the design of the study, had no role in data collection and analysis, had no role in decision to publish, and contributed in the writing of the manuscript.